TFF Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TFF Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q3 2024.
  • TFF Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $568K, a 25.9% decline year-over-year.
  • TFF Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $590K, a 291% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $568K -$199K -25.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-20
Q2 2024 $608K -$217K -26.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q3 2023 $766K -$189K -19.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-20
Q2 2023 $826K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q3 2022 $956K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q3 2020 $1.48M $546K +$775K Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $704K $295K -$191K -39.3% Apr 1, 2020 Jun 30, 2020 10-Q 2020-11-05
Q1 2020 $895K $426K +$305K +251% Jan 1, 2020 Mar 31, 2020 10-Q 2020-11-05
Q4 2019 $590K $211K Oct 1, 2019 Dec 31, 2019 10-K 2020-03-27
Q3 2019 -$229K -$291K -469% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $486K -$687K -58.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 $121K Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q3 2018 $62.1K Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-09
Q2 2018 $1.17M Apr 1, 2018 Jun 30, 2018 10-Q 2019-12-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.